1. American Association of Clinical Endocrinologists: Comprehensive Type 2 Diabetes Management Algorithm 2016. Endocr Pract. 2016;22:84–113.
  2. Solomon, SD, Chew E, Duh EJ, et al. Diabetic retinopathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40:412–418.
  3. American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for management of dyslipidemia and prevention of cardiovascular disease.
  4. American Diabetes Association. Glycemic targets. Sec. 6. In Standards of Medical Care in Diabetes 2015. Diabetes Care. 2017a;40(Suppl. 1):S48–S56.
  5. American Diabetes Association. Pharmacological approaches to glycemic treatment. Sec. 8. In Standards of Medical Care in Diabetes – 2017b. Diabetes Care. 2015;40(Suppl. 1):S64–S74.
  6. American Diabetes Association. Promoting health and reducing disparities in populations. Sec. 1. In Standards of Medical Care in Diabetes 2015. Diabetes Care. 2017c;40(Suppl.1):S6–S10.
  7. Bailey T. Options for combination therapy in type 2 diabetes: comparison of the ADA/EASD position statement and AACE/ACE algorithm. Am J Med. 2013;126(9 Suppl 1):S10–S20.
  8. Center for Disease Control and Prevention. Chronic disease prevention and health promotion. 2016. Accessed March 8, 2017.
  9. Chamberlain J, Rhinehart A, Shaefer C, Neuman A. Diagnosis and management of diabetes: Synopsis of the 2016 American Diabetes Association standards of medical care in diabetes. Ann Intern Med. 2016; 164: 542-552.
  10. Segal AR, Vootla T, Beaser RS. Insulin: making sense of current options. Endocrinol Metab Clin North Am. 2016;45(4):845–874.
  11. Roth EG, Girling LM, Chard S, et al. Diabetes and the motivated patient: understanding perlocutionary effect in health communication. Health Commun. 2017;32(4):502-508.
  12. American Diabetes Association. Diagnosis and classification of diabetes Mellitus. Diabetes Care. 2010;33(suppl 1):S62-S69.
  13. Baptista DR,Wiens A, Pontarolo R, Regis L, Reis WC, Correr CJ. The chronic care model for type 2 diabetes: a systematic review. Diabetol Metab Syndr. 2016;8:7.
  14. Hewston P, Deshpande N. The short version of the activities-specific balance confidence scale for older adults with diabetes-convergent, discriminant and concurrent validity: a pilot study. Can J Diabetes. 2017 Mar 3. pii: S1499-2671(16)30205-2. doi: 10.1016/j.jcjd.2016.10.007. [Epub ahead of print]
  15. American Diabetes Association. Strategies for improving care. Diabetes Care. 2016;39(Supplement 1): S6-S12.
  16. American Diabetes Association. Standards of medical care in diabetes—2017. Accessed March 8, 2017.
  17. American Diabetes Association. Prevention or delay of type 2 diabetes. Diabetes Care. 2016;39(Suppl 1):S36-S38.
  18. American Diabetes Association. Management of diabetes in pregnancy. Diabetes Care. 2016; 39(suppl 1):S94-S98.
  19. American Diabetes Association. Diabetes care in the hospital. Diabetes Care. 2016;39(Suppl 1): S99-S10.
  20. American Diabetes Association. Children and adolescents. Diabetes Care. 2016; 39(suppl 1):S86-S93.
  21. American Diabetes Association. Microvascular complications and foot care. Diabetes Care. 2016;39(suppl 1): S72-S80.
  22. American Association of Clinical Endocrinologists. Management of common comorbidities of diabetes. Accessed March 8, 2017.
  23. Micha R, Peñalvo JL, Cudhea F, et al. Association Between Dietary Factors and Mortality From Heart Disease, Stroke, and Type 2 Diabetes in the United States. JAMA. 2017;317(9):912-924. doi: 10.1001/jama.2017.0947.
  24. Otto MC, Afshin A, Micha R, et al; Global Burdgen of Diseases, Injuries, and Risk Factors Metabolic Risk Factors of Chronic Diseases Expert Group; Nutrition and Chronic Diseases Expert Group (NutriCoDE). The impact of dietary and metabolic risk factors on cardiovascular diseases and type 2 diabetes mortality in Brazil. PLoS One. 2016;11(3):e0151503. doi: 10.1371/journal.pone.0151503. eCollection 2016.
  25. Yang CJ, Hsu HY, Lu CH, et al. Do we underestimate influences of diabetic mononeuropathy or polyneuropathy on hand functional performance and life quality? J Diabetes Investig. 2017 Mar 7. doi: 10.1111/jdi.12649. [Epub ahead of print]
  26. Stino AM, Smith AG. Peripheral neuropathy in prediabetes and the metabolic syndrome. J Diabetes Investig. 2017 Mar 7. doi: 10.1111/jdi.12650. [Epub ahead of print]
  27. van der Berg JD, de Waard EA, Bosma H, et al. Replacement effects of sedentary time on metabolic outcomes-The Maastricht Study. Med Sci Sports Exerc. 2017 Mar 3. doi: 10.1249/MSS.0000000000001248. [Epub ahead of print]
  28. Strain WD, Agarwal AS, Paldánius PM. Individualizing treatment targets for elderly patients with type 2 diabetes: factors influencing clinical decision making in the 24-week, randomized INTERVAL study. Aging (Albany NY). 2017 Mar 5. doi: 10.18632/aging.101188. [Epub ahead of print]
  29. Brahimaj A, Ligthart S, Ghanbari M, et al. Novel inflammatory markers for incident pre-diabetes and type 2 diabetes: the Rotterdam Study. Eur J Epidemiol. 2017 Mar 3. doi: 10.1007/s10654-017-0236-0. [Epub ahead of print]
  30. Hutchison AT, Wittert GA, Heilbronn LK. Matching meals to body clocks-impact on weight and glucose metabolism. Nutrients. 2017;9(3). pii: E222. doi: 10.3390/nu9030222.
  31. Wise J. Complications are more common in young people with type 2 diabetes than type 1. BMJ. 2017 Mar 1;356:j1082. doi: 10.1136/bmj.j1082.
  32. Kuhn A, Park J, Ghazi A, Aroda VR. Intensifying treatment beyond monotherapy in type 2 diabetes mellitus: where do newer therapies fit? Curr Cardiol Rep. 2017;19(3):25. doi: 10.1007/s11886-017-0832-3.
  33. Reusch JE, Manson JE. Management of type 2 diabetes in 2017: getting to goal. JAMA. 2017 Mar 1. doi: 10.1001/jama.2017.0241. [Epub ahead of print]